News

Kimberly-Clark, a global health and hygiene company and I-Flow, a healthcare company that develops and markets low-cost drug delivery systems and products for post-surgical pain relief and surgical

Blue Marble Energy and Bionavitas have entered into a partnership in which Blue Marble Energy will produce biochemicals from microalgae supplied by Bionavitas. Based in Redmond, Washington, Bionavitas

The FDA has approved CSL Behring’s Berinert for the treatment of acute abdominal attacks and facial swelling associated with hereditary angioedema (HAE). Berinert, a protein product derived from

Ipsen and Braintree Laboratories have signed an agreement for the exclusive manufacturing, marketing and distribution rights of the latter’s proprietary formulation – BLI-800, in colonic cleansing before colonoscopy

Spectrum Pharmaceuticals (Spectrum) has received a Complete Response Letter from the FDA regarding its supplemental New Drug Application (sNDA) for Fusilev (levoleucovorin) for injection. It is intended for

Avanir Pharmaceuticals has released the results from the confirmatory double-blind phase III star trial evaluating two doses of the investigational drug Zenvia compared to placebo in the treatment

Pieris has reported continued progress in the development of its lead therapeutic program for the clinic. Under its manufacturing agreement with Wacker Biotech, Pieris has completed the first

Stem Cell Therapy’s to be subsidiary, Histostem has been awarded US Patent Number 7,582,477 B2, entitled: “Method of Isolating and Culturing Mesenchymal Stem Cell Derived from Cryopreserved Umbilical

The FDA’s Cellular, Tissue and Gene Therapies Advisory Committee has reviewed Fibrocell Science’s azfibrocel-T, an autologous cell therapy being investigated for the treatment of moderate-to-severe nasolabial fold wrinkles